Evaxion A (EVAX) Receivables Refunds (2019 - 2023)
Evaxion A posted quarterly Receivables Refunds of $815000.0 for Q4 2023, up 3.3% year-on-year from $789000.0 in Q4 2022, and up 3.3% on a QoQ basis from $789000.0 in Q4 2022.
Evaxion A (EVAX) has 5 years of Receivables Refunds data on file, last reported at $815000.0 in Q4 2023.
- For the quarter ending Q4 2023, Receivables Refunds rose 3.3% year-over-year to $815000.0; the trailing twelve-month figure through Dec 2023 stood at $815000.0 (up 3.3% YoY), and the FY2023 full-year result was $815000.0, up 3.3% from the prior year.
- Receivables Refunds for Q4 2023 stood at $815000.0, up from $789000.0 in the prior quarter.
- Across five years, Receivables Refunds topped out at $1.6 million in Q1 2021 and bottomed at $789000.0 in Q4 2022.
- The 5-year median for Receivables Refunds is $1.1 million (2021), against an average of $1.2 million.
- The widest annual swing landed in 2020, when Receivables Refunds soared 71.84%; it then slumped 40.82% in 2021.
- A 5-year view of Receivables Refunds shows it stood at $824000.0 in 2019, then jumped by 71.84% to $1.4 million in 2020, then plunged by 40.82% to $838000.0 in 2021, then declined by 5.85% to $789000.0 in 2022, then increased by 3.3% to $815000.0 in 2023.
- The last three Receivables Refunds figures came in at $815000.0 (Q4 2023), $789000.0 (Q4 2022), and $838000.0 (Q4 2021), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Refund Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 815,000.00 |
| Dec 31, 2022 | 789,000.00 |
| Dec 31, 2021 | 838,000.00 |
| Sep 30, 2021 | 1.55 Mn |
| Jun 30, 2021 | 1.38 Mn |
| Mar 31, 2021 | 1.61 Mn |
| Dec 31, 2020 | 1.42 Mn |
| Dec 31, 2019 | 824,000.00 |